The Pennant Group (PNTG) Competitors $31.14 +0.64 (+2.10%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PNTG vs. USPH, GH, OPCH, SHC, BTSG, VCYT, SGRY, LFST, CON, and PRVAShould you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include U.S. Physical Therapy (USPH), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "medical" sector. The Pennant Group vs. U.S. Physical Therapy Guardant Health Option Care Health Sotera Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group Concentra Group Holdings Parent Privia Health Group U.S. Physical Therapy (NYSE:USPH) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership, community ranking and profitability. Do analysts recommend USPH or PNTG? U.S. Physical Therapy currently has a consensus target price of $105.00, indicating a potential upside of 7.33%. The Pennant Group has a consensus target price of $38.25, indicating a potential upside of 22.83%. Given The Pennant Group's stronger consensus rating and higher probable upside, analysts clearly believe The Pennant Group is more favorable than U.S. Physical Therapy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score U.S. Physical Therapy 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67The Pennant Group 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has more risk & volatility, USPH or PNTG? U.S. Physical Therapy has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 2.02, suggesting that its share price is 102% more volatile than the S&P 500. Does the MarketBeat Community favor USPH or PNTG? U.S. Physical Therapy received 212 more outperform votes than The Pennant Group when rated by MarketBeat users. Likewise, 56.25% of users gave U.S. Physical Therapy an outperform vote while only 47.06% of users gave The Pennant Group an outperform vote. CompanyUnderperformOutperformU.S. Physical TherapyOutperform Votes25256.25% Underperform Votes19643.75% The Pennant GroupOutperform Votes4047.06% Underperform Votes4552.94% Does the media prefer USPH or PNTG? In the previous week, The Pennant Group had 1 more articles in the media than U.S. Physical Therapy. MarketBeat recorded 4 mentions for The Pennant Group and 3 mentions for U.S. Physical Therapy. The Pennant Group's average media sentiment score of 1.10 beat U.S. Physical Therapy's score of 0.91 indicating that The Pennant Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment U.S. Physical Therapy 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of USPH or PNTG? 85.9% of The Pennant Group shares are held by institutional investors. 1.7% of U.S. Physical Therapy shares are held by insiders. Comparatively, 5.8% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is USPH or PNTG more profitable? U.S. Physical Therapy has a net margin of 3.54% compared to The Pennant Group's net margin of 3.24%. The Pennant Group's return on equity of 13.47% beat U.S. Physical Therapy's return on equity.Company Net Margins Return on Equity Return on Assets U.S. Physical Therapy3.54% 8.11% 3.85% The Pennant Group 3.24%13.47%3.81% Which has higher valuation and earnings, USPH or PNTG? U.S. Physical Therapy has higher earnings, but lower revenue than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than U.S. Physical Therapy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioU.S. Physical Therapy$645.70M2.29$28.24M$0.94104.07The Pennant Group$652.30M1.64$13.38M$0.6845.79 SummaryThe Pennant Group beats U.S. Physical Therapy on 10 of the 18 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get The Pennant Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PNTG vs. The Competition Export to ExcelMetricThe Pennant GroupHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.07B$958.55M$5.38B$8.84BDividend YieldN/A1.94%5.13%4.09%P/E Ratio45.7938.40105.1417.83Price / Sales1.644.231,233.15158.41Price / Cash40.6525.4440.4136.29Price / Book5.712.937.096.50Net Income$13.38M-$10.72M$119.65M$226.22M7 Day Performance-0.92%2.29%2.25%4.03%1 Month Performance-8.81%1.91%-2.33%4.92%1 Year Performance126.47%430.62%33.98%29.30% The Pennant Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PNTGThe Pennant Group3.6624 of 5 stars$31.14+2.1%$38.25+22.8%+126.5%$1.05B$544.89M45.795,791Positive NewsUSPHU.S. Physical Therapy2.0226 of 5 stars$98.72+1.8%$105.00+6.4%+12.1%$1.49B$645.70M104.646,720Analyst ForecastPositive NewsGHGuardant Health3.9877 of 5 stars$31.67+2.2%$40.60+28.2%+40.6%$3.91B$563.95M-7.331,779OPCHOption Care Health4.9817 of 5 stars$22.77+1.2%$30.83+35.4%-23.3%$3.87B$4.30B18.877,802Positive NewsSHCSotera Health4.2362 of 5 stars$12.68+2.2%$16.50+30.1%-6.6%$3.59B$1.05B49.643,000Analyst ForecastBTSGBrightSpring Health Services2.8925 of 5 stars$18.76+0.1%$16.79-10.5%N/A$3.27B$8.83B-72.1235,000Positive NewsVCYTVeracyte4.1662 of 5 stars$38.72-0.6%$41.25+6.5%+51.6%$3.00B$425.33M-259.60790SGRYSurgery Partners3.1211 of 5 stars$22.89-2.0%$38.71+69.1%-29.9%$2.91B$2.99B-48.6713,500Analyst ForecastLFSTLifeStance Health Group1.7824 of 5 stars$7.23-1.1%$8.50+17.6%+15.6%$2.77B$1.06B-28.129,325CONConcentra Group Holdings ParentN/A$21.67+0.9%$28.50+31.5%N/A$2.76B$1.88B0.0011,000PRVAPrivia Health Group3.3925 of 5 stars$21.34+1.2%$25.07+17.5%-2.8%$2.56B$1.66B211.771,102Positive News Related Companies and Tools Related Companies USPH Competitors GH Competitors OPCH Competitors SHC Competitors BTSG Competitors VCYT Competitors SGRY Competitors LFST Competitors CON Competitors PRVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PNTG) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Pennant Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share The Pennant Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.